Zobrazeno 1 - 10
of 800
pro vyhledávání: '"MORIHITO OKADA"'
Autor:
Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen‐Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nishio
Publikováno v:
Molecular Oncology, Vol 18, Iss 2, Pp 305-316 (2024)
The phase III IMPACT study (UMIN000044738) compared adjuvant gefitinib with cisplatin plus vinorelbine (cis/vin) in completely resected epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC). Although the primary endpo
Externí odkaz:
https://doaj.org/article/5ef9670861fa45fda1c2e13f031a8170
Autor:
Norifumi Tsubokawa, Takahiro Mimae, Risa Ito, Ryuma Sasai, Kouichi Hirano, Atsushi Kamigaichi, Nobutaka Kawamoto, Yoshihiro Miyata, Morihito Okada
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Background Pleurodesis is often performed for air leaks; however, the ideal materials and timing of the procedure remain controversial. We investigated the efficacy of pleurodesis using different materials and timing. Methods We retrospectiv
Externí odkaz:
https://doaj.org/article/53349d18a6da47508859871775234054
Autor:
Tetsuya Isaka, Hiroyuki Adachi, Kotaro Murakami, Jun Miura, Noritake Kikunishi, Naoko Shigeta, Yujin Kudo, Yoshihiro Miyata, Morihito Okada, Norihiko Ikeda, Hiroyuki Ito
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The recurrence site that influences post-recurrence survival (PRS) in patients with non-small cell lung cancer (NSCLC) undergoing surgery and the preoperative predictors of recurrence remain unclear. Methods Cohorts 1 and 2 had 45
Externí odkaz:
https://doaj.org/article/a84aefd986c0416eaa3555fed8974e61
Autor:
Kiyofumi Shimoji, Taku Nakashima, Takeshi Masuda, Masashi Namba, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Yasushi Horimasu, Takahiro Mimae, Shintaro Miyamoto, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Morihito Okada, Noboru Hattori
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background The prognosis of patients with lung cancer accompanied by interstitial pneumonia is poorer than that of patients with lung cancer but without interstitial pneumonia. Moreover, the available therapeutic interventions for lung cance
Externí odkaz:
https://doaj.org/article/adb9342598e843a3a3a376c7407dd241
Autor:
Yasuhiro Tsutani, Yoshihiro Miyata, Kenji Suzuki, Fumihiro Tanaka, Hiroyuki Ito, Yoshinori Yamashita, Morihito Okada
Publikováno v:
Cancers, Vol 16, Iss 13, p 2363 (2024)
The objective of this study was to evaluate the relationship between pathologic response and survival in patients with clinical stage II/IIIA nonsquamous non-small-cell lung cancer (NSCLC) who intended to undergo neoadjuvant chemotherapy with bevaciz
Externí odkaz:
https://doaj.org/article/f805d65872e24bb0b61dd9abf827198d
Autor:
Junko Tanizaki, MD, PhD, Hiroaki Kuroda, MD, PhD, Toshihide Yokoyama, MD, Makoto Takahama, MD, PhD, Hiroyasu Shoda, MD, PhD, Atsushi Nakamura, MD, PhD, Yoshitaka Kitamura, MD, PhD, Nobuaki Mamesaya, MD, PhD, Yoshihisa Kadota, MD, PhD, Kenji Sawa, MD, PhD, Kyoichi Okishio, MD, PhD, Morihito Okada, MD, PhD, Chihiro Suminaka, MS, Kenta Noda, PhD, Kazuko Sakai, PhD, Yasutaka Chiba, PhD, Kazuto Nishio, MD, PhD, Kenji Chamoto, PhD, Tasuku Honjo, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Hidetoshi Hayashi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100590- (2023)
Introduction: Perioperative treatment in NSCLC has gained marked attention with the introduction of immune checkpoint inhibitors. Such a paradigm shift has given us additional opportunities to evaluate potential biomarkers in patients with these cura
Externí odkaz:
https://doaj.org/article/3f386ee3f72d427a96a00d99cb19bacc
Autor:
Yoshihisa Shimada, Yusuke Yoshioka, Yujin Kudo, Takahiro Mimae, Yoshihiro Miyata, Hiroyuki Adachi, Hiroyuki Ito, Morihito Okada, Tatsuo Ohira, Jun Matsubayashi, Takahiro Ochiya, Norihiko Ikeda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Lymphovascular invasion (LVI) is a fundamental step toward the spread of cancer. Extracellular vesicles (EVs) promote cellular communication by shuttling cargo, such as microRNAs (miRNAs). However, whether EV-associated miRNAs serve as bioma
Externí odkaz:
https://doaj.org/article/b08ff0f79c9c45afa86f05afede822a2
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The prognostic impact of EGFR mutation as major targetable somatic gene variant on lung adenocarcinoma is controversial. KRAS is another major somatic variant in lung adenocarcinoma, and a therapeutic agent for KRAS G12C became av
Externí odkaz:
https://doaj.org/article/6479d0a9753f4934a6f9fa62e911d4bd
Autor:
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Publikováno v:
Thoracic Cancer, Vol 14, Iss 4, Pp 381-388 (2023)
Abstract Background The S100 calcium‐binding protein A4 (S100A4) and the accumulation of [18F]‐fluoro‐2‐deoxy‐D‐glucose (FDG) in noncancerous interstitial pneumonia (IP) area are predictors of postoperative acute exacerbation (AE) of IP a
Externí odkaz:
https://doaj.org/article/f7bccb167c6c43f68e4fe08ef387262a
Autor:
Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, Hiroto Narimatsu, Kotaro Murakami, Shunsuke Shigefuku, Noritake Kikunishi, Naoko Shigeta, Kozue Watabe, Yujin Kudo, Yoshihiro Miyata, Morihito Okada, Norihiko Ikeda, Hiroyuki Ito
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesWe aimed to clarify the differences in prognosis between wedge resection and segmentectomy performed for cN0 non-small cell lung cancer (NSCLC) measuring ≤ 2 cm, with consolidation tumor ratio (CTR) > 0.25.MethodsThis multicenter study in
Externí odkaz:
https://doaj.org/article/7cbed5c59e8446e09bb72cbbfce0af06